Z-Arg(PMC)-OH.CHA

Catalog No. :
ACWXIF507
CAS No. :
112160-33-5
Molecular Formula :
C34H51N5O7S
Molecular Weight :
673.88

IUPAC Name:cyclohexanamine N2-((benzyloxy)carbonyl)-Nw-((2,2,5,7,8-pentamethylchroman-6-yl)sulfonyl)-L-argininate

Z-Arg(PMC)-OH.CHA structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$177.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameZ-Arg(PMC)-OH.CHA
IUPAC Namecyclohexanamine N2-((benzyloxy)carbonyl)-Nw-((2,2,5,7,8-pentamethylchroman-6-yl)sulfonyl)-L-argininate
MDL No.MFCD00153323
Molecular FormulaC34H51N5O7S
Molecular Weight673.88
SMILESO=C(N[C@H](C(O)=O)CCCNC(NS(=O)(C1=C(C)C(C)=C2C(CCC(C)(C)O2)=C1C)=O)=N)OCC3=CC=CC=C3.NC4CCCCC4
InChI KeyMYXGDQOQWHFITA-FTBISJDPSA-N
SynonymN-ALPHA-CBZ-NG-2,2,5,7,8-PENTAMETHYLCHROMAN-6-SULFONYL-L-ARGININE CYCLOHEXYLAMMONIUM SALT;N-ALPHA-CARBOBENZOXY-N-OMEGA-(2,2,5,7,8-PENTAMETHYLCHROMAN-6-SULFONYL)-L-ARGININE CYCLOHEXYLAMMONIUM SALT;Z-ARGININE(PMC)-OH CHA;Z-ARG(PMC)-OH CHA;Z-N-OMEGA-(2,2,5,7,8-PENTAMETHYLCHROMAN-6-SULFONYL)-L-ARGININE CYCLOHEXYLAMMONIUM SALT;Cbz-L-Arg(Pmc)-OH.CHA;N-Cbz-N'-(2,2,5,7,8-Pentamethylchroman-6-sulfonyl)-L-arginine cyclohexylammonium salt;Z-Arg(Pmc)-OH
CAS No.112160-33-5
PubChem CID50878589

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWXIF507 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWXIF507 route product structure diagram
    ACWXIF507112160-33-5
Inquiry

2. ACWXIF507 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWXIF507 route product structure diagram
    ACWXIF507112160-33-5
Inquiry

Comments (0)